Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

Novo Nordisk A/S shares fell over 4% premarket Friday, heading for lows last seen in early August, amid concerns over pricing ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of ...

Mounjaro (tirzepatide) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as a liquid solution that you inject under your skin, typically once per week. Mounjaro ...

Under the care of Dr Wendy Denning, a private GP in London, I began on a 0.25mg weekly dose ... I swapped Ozempic for Mounjaro, known as the King Kong of weight-loss drugs for its dual action ...

The weight loss medication Ozempic has become the most talked-about drug in Hollywood, with several celebrities like Kyle Richards and Garcelle Beauvais denying that they’ve taken it to shed pounds.

Scots nurse Susan McGowan died after just two low doses of a weight-loss jab. Susan, 58, took medical advice before using tirzepatide, known as brand name Mounjaro. Her death certificate said ...